CSF3 and neutropenia: The majority of the 140 patients in the prophylactic G-CSF group were treated with pegylated G-CSF two days prior to CAR T, whereas most of the 57 patients in the control group ultimately received G-CSF starting a median of six days after CAR T to treat neutropenia.